MC
PCRX icon

Maverick Capital’s Pacira BioSciences PCRX Stock Holding History

Maverick Capital’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,823
Closed -$233K – 448
2023
Q2 		$233K Buy
+5,823
New +$241K 0.01% 380
2021
Q3 		– Sell
-1,108
Closed -$67K – 762
2021
Q2 		$67K Buy
+1,108
New +$70.1K ﹤0.01% 589
2020
Q2 		– Sell
-48,159
Closed -$1.61M – 648
2020
Q1 		$1.61M Sell
48,159
-53,060
-52% -$2.2M 0.03% 217
2019
Q4 		$4.58M Sell
101,219
-71,161
-41% -$3.02M 0.07% 144
2019
Q3 		$6.56M Buy
+172,380
New +$6.88M 0.1% 88
2016
Q2 		– Sell
-1,610,932
Closed -$85.3M – 147
2016
Q1 		$85.3M Buy
+1,610,932
New +$94.2M 1.35% 27

Other funds holding PCRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return